机译:前列腺活检转诊决策的优化
Department of Clinical Decision Support Solutions, Philips Research North America, Briarcliff Manor, New York 10510;
Edward P. Fitts Department of Industrial and Systems Engineering, North Carolina State University,Raleigh, North Carolina 27695;
Department of Mechanical and Industrial Engineering, University of Massachusetts, Amherst, Massachusetts 01003;
Division of Health Care Policy and Research, Mayo Clinic, Rochester, Minnesota 55905;
Department of Surgery, School of Medicine, Duke University, Durham, North Carolina 27710;
partially observable markov decision process; PSA screening; biopsy; control-limit policy; stopping time problem;
机译:在初级保健机构中进行前列腺穿刺活检转诊的共同决策工具:将癌症风险与预期寿命相结合
机译:基于活检的8-蛋白质前列腺癌预后分析的成本效果,以优化格里森3 + 3和3 + 4早期前列腺癌的治疗决策
机译:基于活检的8-蛋白前列腺癌预后分析的成本-效果优化了格里森3 + 3和3 + 4早期前列腺癌的治疗决策
机译:使用2D / 3D超声对前列腺活检进行实时刚性定位运动补偿的优化
机译:前列腺穿刺活检的准确性,可将低级前列腺癌患者分配到主动监护下。
机译:基于活检的8-蛋白质前列腺癌预后分析的成本-效果优化了格里森3 + 3和3 + 4早期前列腺癌的治疗决策
机译:前列腺活检转诊决定的优化